Melanocortin-4-receptor agonist studied in central-signaling models.
For research use only. Not for human or veterinary use. No claims of safety, efficacy or therapeutic benefit.
Central melanocortin signaling; sexual desire and related distress. Phase 3 trials in premenopausal women with hypoactive sexual desire disorder reported improvements in desire and distress scores; this is not a general sexual-performance claim.
Clinical findings apply to the studied formulation, population and indication. They do not establish equivalence, safety or therapeutic efficacy of this research product.
PMID: 31599840
Contact the Avitus team to confirm available presentations, product specifications and pricing for your research requirements.